The aim of the study was to determine whether there is any justification for measuring NE, S100B, and NSE in patients with T2DM and NfT2DM who have recovered from COVID-19, suggesting that these proteins might play a role in building a predictive model for PCS. This evidence concerns the gene S100B and type 2 diabetes mellitus.